Assessment of medication adherence among Lebanese adult patients with non-communicable diseases during COVID-19 lockdown: a cross-sectional study.
COVID-19
Lebanon
adherence
diseases
medications
non-communicable
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
01
2023
accepted:
25
05
2023
medline:
10
7
2023
pubmed:
7
7
2023
entrez:
7
7
2023
Statut:
epublish
Résumé
Medical treatment is considered a cornerstone in non-communicable diseases (NCDs) management, lack of adherence remains the main challenge that may compromise optimal therapeutic outcome achievement. This study aimed to evaluate treatment adherence levels and associated factors among Lebanese adult patients with non-communicable diseases. A cross-sectional survey conducted during the COVID-19 lockdown imposed by the Lebanese Government (between September 2020 and January 2021) enrolled 263 adult patients through an anonymous online questionnaire to assess adherence to medications using the Lebanese Medication Adherence Scale (LMAS-14). Of the total sample, 50.2% showed low adherence with a total mean adherence score of 4.41 ± 3.94. The results showed that depression ( Our study shed light on the factors affecting medication adherence in patients with non-communicable diseases. It showed that depression and peptic ulcer were associated with lower adherence, contrary to older age, exercising, having chronic kidney disease, and a higher socioeconomic status.
Sections du résumé
Background
UNASSIGNED
Medical treatment is considered a cornerstone in non-communicable diseases (NCDs) management, lack of adherence remains the main challenge that may compromise optimal therapeutic outcome achievement.
Purpose
UNASSIGNED
This study aimed to evaluate treatment adherence levels and associated factors among Lebanese adult patients with non-communicable diseases.
Materials and methods
UNASSIGNED
A cross-sectional survey conducted during the COVID-19 lockdown imposed by the Lebanese Government (between September 2020 and January 2021) enrolled 263 adult patients through an anonymous online questionnaire to assess adherence to medications using the Lebanese Medication Adherence Scale (LMAS-14).
Results
UNASSIGNED
Of the total sample, 50.2% showed low adherence with a total mean adherence score of 4.41 ± 3.94. The results showed that depression (
Conclusion
UNASSIGNED
Our study shed light on the factors affecting medication adherence in patients with non-communicable diseases. It showed that depression and peptic ulcer were associated with lower adherence, contrary to older age, exercising, having chronic kidney disease, and a higher socioeconomic status.
Identifiants
pubmed: 37415710
doi: 10.3389/fpubh.2023.1145016
pmc: PMC10322190
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1145016Informations de copyright
Copyright © 2023 Malaeb, Sacre, Mansour, Haddad, Sarray El Dine, Fleihan, Hallit, Salameh and Hosseini.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Clin Diagn Res. 2013 Mar;7(3):462-6
pubmed: 23634397
J Card Fail. 2013 May;19(5):317-24
pubmed: 23663814
J Epidemiol Glob Health. 2016 Sep;6(3):169-76
pubmed: 26599284
Clin Ther. 2001 Aug;23(8):1296-310
pubmed: 11558866
J Hosp Med. 2012 Jul-Aug;7(6):470-5
pubmed: 22473754
East Mediterr Health J. 2011 Apr;17(4):356-63
pubmed: 22259896
Stroke. 2013 Mar;44(3):870-947
pubmed: 23370205
East Mediterr Health J. 2019 Apr 25;25(3):149-159
pubmed: 31054225
AIDS Behav. 2012 Aug;16(6):1511-21
pubmed: 21811842
Cureus. 2020 Sep 6;12(9):e10270
pubmed: 33042708
Value Health. 2014 Mar;17(2):288-96
pubmed: 24636389
Stroke. 1997 Jul;28(7):1507-17
pubmed: 9227708
J Clin Med Res. 2019 Aug;11(8):583-592
pubmed: 31413770
Medscape J Med. 2008;10(9):225
pubmed: 19008986
Pharm Pract (Granada). 2018 Oct-Dec;16(4):1291
pubmed: 30637030
Int J Clin Pharm. 2021 Aug;43(4):918-927
pubmed: 33201490
Ann Pharmacother. 2006 Jun;40(6):1143-50
pubmed: 16735667
J Gen Intern Med. 2011 Oct;26(10):1175-82
pubmed: 21533823
Int J Hypertens. 2018 May 20;2018:3934296
pubmed: 29887993
Stroke Res Treat. 2018 Nov 27;2018:3238165
pubmed: 30598741
Am J Kidney Dis. 2010 Sep;56(3):439-46
pubmed: 20674113
J Epidemiol Glob Health. 2016 Sep;6(3):157-67
pubmed: 26232704
Health Psychol. 2004 Mar;23(2):207-18
pubmed: 15008666
Expert Rev Neurother. 2008 Oct;8(10):1563-71
pubmed: 18928348
J Clin Hypertens (Greenwich). 2015 May;17(5):381-8
pubmed: 25619545
Heart Lung. 2012 Mar-Apr;41(2):107-14
pubmed: 22054720
JAMA. 2020 Feb 25;323(8):707-708
pubmed: 31971553
BMC Public Health. 2019 Oct 16;19(1):1300
pubmed: 31619202
Curr Vasc Pharmacol. 2006 Apr;4(2):155-60
pubmed: 16611157
Pharm Pract (Granada). 2006 Apr;4(2):88-94
pubmed: 25247005
J Ren Care. 2012 Mar;38(1):34-42
pubmed: 22369594